Nampt-IN-3
Nampt-IN-3 (Compound 35) simultaneously inhibit nicotinamide phosphoribosyltransferase (NAMPT) and HDAC with IC50s of 31 nM and 55 nM, respectively. Nampt-IN-3 effectively induces cell apoptosis and autophagy and ultimately leads to cell death[1].
Product Specifications
CAS Number
[2121591-52-2]
UNSPSC
12352005
Target
Apoptosis; Autophagy; HDAC; NAMPT
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nampt-in-3.html
Concentration
10mM
Purity
98.97
Solubility
DMSO : 130 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C(C2=CN(CC3=CC=C(C(NC4=CC=CC=C4N)=O)C=C3)N=N2)C=C1)NCC5=CC=CN=C5
Molecular Formula
C29H25N7O2
Molecular Weight
503.55
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
DMBT1 (Deleted in Malignant Brain Tumors 1 Protein, GlycoProtein 340, Gp-340, Hensin, Salivary Agglutinin, SAG, Surfactant Pulmonary-Associated D-Binding Protein, DMBT1, GP340) (MaxLight 750)
DMBT1 (Deleted in Malignant Brain Tumors 1 Protein, GlycoProtein 340, Gp-340, Hensin, Salivary Agglutinin, SAG, Surfactant Pulmonary-Associated D-Binding Protein, DMBT1, GP340) (MaxLight 750)
